摘要
肺动脉高压是临床上常见的疾病,其发病机制尚未完全清楚。免疫因素在肺动脉高压的发病机制中起重要作用。自身免疫紊乱、免疫细胞、免疫分子在其发生过程中起着重要作用,免疫抑制疗法为肺动脉高压治疗提供了新的途径。
Pulmonary hypertension is a common disease, and its pathogenesis is not entirely clear. Immune factors play an important role in the pathogenesis of pulmonary hypertension. Autoimmune disorders, immune cells and immune molecules play an important role in the occurrence of pulmonary hypertension. The immunosuppressive therapy provides a new way for pulmonary hypertension treatment.
出处
《国际内科学杂志》
CAS
2009年第3期179-182,共4页
International Journal of Internal Medicine
关键词
肺动脉高压
免疫机制
免疫细胞
免疫分子
Pulmonary arterial hypertension
Immunologic mechanism: Immune cell: Immune molecules